Products List

Product List

Here is an overview of our products.

Please Note: An update has been made to remove the plaster from the administration kit for Berinert^® IV.
Product supplied without the plaster will be from approximately:
500 IU – June/July 2025
1500 IU – late May/June 2025
Product supplied and in circulation with the plaster in the administration kit is still appropriate to use.

Australia Product Information

Australia Consumer Medicine Information

Please Note: An update has been made to remove the plaster from the administration kit for Berinert^® SC.
Product supplied without the plaster will be from approximately:
2000 IU – late May/June 2025
3000 IU – September/October 2025
Product supplied and in circulation with the plaster in the administration kit is still appropriate to use.

The trademarks marked ® are registered by CSL Limited or its affiliates or subsidiaries in one or more jurisdictions, unless indicated otherwise.

Looking down into microscope and taking notes

Report an undesirable effect

If you have encountered any side effect(s) to a CSL Behring product, we encourage you to talk to your doctor, pharmacist, or nurse.

CSL Behring also collects information about undesirable effects in order to monitor product safety and investigate, evaluate and report undesirable effects to appropriate regulatory bodies.
Please click on the following link to report an Adverse Event/Undesirable Effect to a CSL Behring product.

Contact Details for Reporting An Undesirable Effect

Product List

Here is an overview of our products.

Albumex® 4 | Human Albumin 40g/L

Albumex® 20 | Human Albumin 200g/L

Alburex® 5 AU | Human Albumin 50g/L

Alburex® 20 AU | Human Albumin 200g/L

Alburex® 5 NZ | Human Albumin 50g/L

Alburex® 20 NZ | Human Albumin 200g/L

ANDEMBRY® | Garadacimab, solution for injection in pre-filled pen

Beriplex® P/N ǀ Human prothrombin complex, powder for injection - Available July 2024

Beriplex® AU | Human prothrombin complex, powder for injection - Available January 2025

Beriplex® NZ | Human prothrombin complex, powder for injection - Available May 2025

BERINERT® IV | Human C1 esterase inhibitor, intravenous administration

BERINERT® SC | Human C1 esterase inhibitor, subcutaneous administration

BIOSTATE® | Human coagulation factor VIII / von Willebrand factor concentrate (FVIII/VWF concentrate), powder for injection

CMV Immunoglobulin-VF | Human Cytomegalovirus Immunoglobulin

Hepatitis B Immunoglobulin-VF | Human Hepatitis B Immunoglobulin

Hizentra® | Normal immunoglobulin (Human) 20% (20 g/100 mL), subcutaneous injection

Hizentra® AU | Normal immunoglobulin (Human) 20% (20 g/100 mL), subcutaneous injection

Hizentra® NZ | Normal immunoglobulin (Human) 20% (20 g/100 mL), subcutaneous injection

IDELVION® | Recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP), powder for injection

Intragam® P | Human Normal Immunoglobulin

Intragam® 10 | Human Normal Immunoglobulin 10%

MonoFIX®-VF | Human Coagulation Factor IX

Normal Immunoglobulin-VF | Human Normal Immunoglobulin

PRIVIGEN® | Normal immunoglobulin (Human) 10% (100 g/L), intravenous injection

PRIVIGEN® AU | Normal immunoglobulin (Human) 10% (100 g/L), intravenous injection

PRIVIGEN® NZ | Normal immunoglobulin (Human) 10% (100 g/L), intravenous injection

PROTHROMBINEX®-VF | Human prothrombin complex, powder for injection

Rh(D) Immunoglobulin-VF | Human Anti-D Rh(D) Immunoglobulin

RHOPHYLAC® | Rho(D) Immune Globulin Intravenous (Human)

RiaSTAP® | Fibrinogen Concentrate (Human)

Tetanus Immunoglobulin-VF IM | Human Tetanus Immunoglobulin

Tetanus Immunoglobulin-VF IV | Human Tetanus Immunoglobulin (For Intravenous Use)

THROMBOTROL®-VF | Antithrombin III Concentrate (Human)

Zoster Immunoglobulin-VF | Human Zoster Immunoglobulin

Report an undesirable effect